Your browser doesn't support javascript.
loading
Recombinant scFv-Fc Anti-kallikrein 7 Antibody-Loaded Thermosensitive Hydrogels Against Skin Desquamation Disorders.
Laureano, Ana Flávia Santarine; Vigato, Aryane Alves; Puzer, Luciano; de Araujo, Daniele Ribeiro.
Afiliación
  • Laureano AFS; Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital & Harvard Medical School, CNY149 13th Street, Charlestown, Boston, Massachusetts 02129, United States.
  • Vigato AA; Centro de Ciências Naturais e Humanas, Universidade Federal do ABC, Al. da Universidade, s/n-Anchieta, São Bernardo do Campo, SP 09606-045, Brazil.
  • Puzer L; Department of Biomedical Science (BMV), Faculty of Health and Society, Malmö University, Malmö 20506, Sweden.
  • de Araujo DR; Biofilms-Research Center for Biointerfaces, Malmö University, Malmö 20506, Sweden.
ACS Appl Bio Mater ; 7(7): 4486-4496, 2024 Jul 15.
Article en En | MEDLINE | ID: mdl-38886921
ABSTRACT
Human tissue kallikrein-related peptidase 7 (KLK7) is a serine protease implicated in the physiology of skin desquamation, and its uncontrolled activity can lead to chronic diseases such as psoriasis, atopic dermatitis, and Netherton syndrome. For this reason, kallikrein 7 has been identified as a potential therapeutic target. This work aimed to evaluate Pluronic (PL) hydrogels as topical carriers of four specific scFv-Fc antibodies to inhibit KLK7. The hydrogels comprised PL F127 (30% w/v) alone and a binary F127/P123 (28-2% w/v) system. Each formulation was loaded with 1 µg/mL of each antibody and characterized by physicochemical and pharmaceutical techniques, considering antibody-micelle interactions and hydrogel behavior as smart delivery systems. Results showed that the antibodies were successfully loaded into the PL-based systems, and the sol-gel transition temperature was shifted to high values after the P123 addition. The antibodies released from the gels preserved their rheological properties (G' > G'', 35- to 41-fold) and inhibitory activity against KLK7, even after 24 h. This work presented potential agents targeting KLK7 that may provide strategies for treating skin abnormalities.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calicreínas / Hidrogeles Límite: Humans Idioma: En Revista: ACS Appl Bio Mater Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Calicreínas / Hidrogeles Límite: Humans Idioma: En Revista: ACS Appl Bio Mater Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
...